Wasman Jane insider trades
Wasman Jane has filed 13 Form 4s with the SEC that we hold, for SELLAS Life Sciences Group, Inc. (SLS) (Director), Rigel Pharmaceuticals INC (RIGL) (Director) and ATHX (Director). Across all of them we count 1 purchase worth $33.8K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 20,000 shares of SELLAS Life Sciences Group, Inc. worth $33.8K, dated 2025-05-30. The first filing on our record is dated 2022-02-01 and the latest 2026-05-19.
SELLAS Life Sciences Group, Inc. (SLS)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2025-05-30 | P, purchase reported on Form 4 | 20,000 | $33.8K | 2025-06-02 | SEC |
Rigel Pharmaceuticals INC (RIGL)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
ATHX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1352455) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
